SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
- Conditions
- Non-proliferative Diabetic Retinopathy
- Interventions
- Other: Follow-up with regular examination for determination of DR progression
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT04511715
Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 74
- Registration Number
- NCT04482543
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
Low Dose Radiotherapy in COVID-19 Pneumonia
- Conditions
- COVIDSARS (Severe Acute Respiratory Syndrome)
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 5
- Registration Number
- NCT04390412
- Locations
- 🇮🇷
Imam Hossein Hospital, Tehran, Iran, Islamic Republic of
Curcumin and Nanocurcumin in Oral Aphthous Ulcer
- Conditions
- Recurrent Aphthous UlcerRecurrent Aphthous Stomatitis
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 48
- Registration Number
- NCT04385979
- Locations
- 🇮🇷
Mahinbakhshi@Sbmu.Ac.Ir, Tehran, Iran, Islamic Republic of
Correlation Between Oxidative Stress Status and COVID-19 Severity
- Conditions
- Oxidative Stress
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 90
- Registration Number
- NCT04375137
- Locations
- 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of
The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT04360980
- Locations
- 🇮🇷
SBMU, Tehran, Iran, Islamic Republic of
🇮🇷Nooshin Dalili, Tehran, Iran, Islamic Republic of
Favipiravir in Hospitalized COVID-19 Patients
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04359615
- Locations
- 🇮🇷
Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of
Azithromycin in Hospitalized COVID-19 Patients
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04359316
- Locations
- 🇮🇷
Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of
Interferon Beta 1a in Hospitalized COVID-19 Patients
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04350671
- Locations
- 🇮🇷
Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of
Umifenovir in Hospitalized COVID-19 Patients
- Conditions
- COVID-19
- Interventions
- Drug: Interferon-β 1aDrug: Standards of Care
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04350684
- Locations
- 🇮🇷
Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of